Clinical Pathway Information System Market By Type , By Mode of Delivery By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

Description

Clinical Pathway Information System Market

The clinical pathway information system market was valued at $0.8 billion in 2023 and is projected to reach $1.7 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

A clinical pathway information system is specialized software designed for healthcare settings to manage and optimize their operations. This system reduces variations in clinical practice and promotes the standardization of multidisciplinary activities. The clinical pathway information system further facilitates the adoption of evidence-based practice in the clinical settings. The major advantage of using such systems includes improved healthcare delivery, swift coordination, data-driven insights, and enhanced efficiency in patient care. The information system efficiently integrates with the electronic healthcare system, enabling quick access to patient data and rapid documentation procedures in the healthcare facilities.

To promote consistency in patient care and ensure standardization of clinical practices in healthcare settings across the globe, there is a significant demand for clinical pathway information systems. In addition, technological advancements facilitate the assimilation of information systems with other healthcare systems, thereby improving the clinical outcomes. This acts as a major driver of the clinical pathway information system market. Moreover, the adoption of information systems is witnessing a surge as they help the healthcare facilities to avoid unnecessary operational costs through improved resource utilization. In the coming future, the convergence of clinical pathway information system and telemedicine is anticipated to be a prominent trend. This convergence is projected to facilitate the transfer of patient data among different healthcare facilities and foster the development of suitable applications that promote remote patient care.

However, the implementation of clinical pathway information system is a highly cost-intensive and intricate process with expenses associated with maintenance & updates and challenges pertaining to assimilation with the existing infrastructure. These factors hamper the growth of the market significantly. Furthermore, complete dependence on technology holds the potential to disrupt the entire workflow at times of system outages and technical issues, deterring several medical facilities from adopting the advanced information systems. On the contrary, upsurge in the utility of electronic health records (EHR) systems among several physicians and doctors is expected to open new avenues for market expansion. According to the statistics published by Statista, a global data and business intelligence platform, approximately 88% of the total doctors were using EHR systems in the U.S. The platform further predicts the figure to rise in the future.

Segment Review

The clinical pathway information system market is segmented into type, mode of delivery, end user, and region. On the basis of type, the market is divided into group order type, embodied variant type, and reconstructed information type. As per mode of delivery, it is classified into on-premises, cloud-based, and web-based. Depending on end user, it is categorized into hospitals, ambulatory care centers, specialty clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Competition Analysis

The key players operating in the global clinical pathway information system market include McKesson Corporation, Civica, GE Healthcare, Koninklijke Philips N.V., EPIC Systems Corporation, Optum, Inc., PointClickCare, Cerner Corporation, Philips Healthcare, and Athenahealth. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Expanded list for Company Profiles
Reimbursement Scenario

Key Market Segments

By Type

Group Order Type
Embodied Variant Type
Reconstructed Information Type

By Mode Of Delivery

On-Premises
Cloud-Based
Web-Based

By End User

Hospitals
Ambulatory Care Centers
Specialty Clinics
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

Key Market Players:

McKesson Corporation
Civica
GE Healthcare
Koninklijke Philips N.V.
EPIC Systems Corporation
Optum, Inc.
PointClickCare
Cerner Corporation
Philips Healthcare
Athenahealth

Product Code: A323981

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY TYPE

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
4.2. Group Order Type
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Embodied Variant Type
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
4.4. Reconstructed Information Type
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country

CHAPTER 5: CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY MODE OF DELIVERY

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Mode of Delivery
5.2. On-Premises
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. Cloud-Based
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
5.4. Web-Based
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country

CHAPTER 6: CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY END USER

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
6.3. Ambulatory Care Centers
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
6.4. Specialty Clinics
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
6.5. Others
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country

CHAPTER 7: CLINICAL PATHWAY INFORMATION SYSTEM MARKET, BY REGION

7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Type
- 7.2.3. Market Size and Forecast, By Mode of Delivery
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Clinical Pathway Information System Market
  - 7.2.6.1. Market Size and Forecast, By Type
  - 7.2.6.2. Market Size and Forecast, By Mode of Delivery
  - 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Clinical Pathway Information System Market
  - 7.2.7.1. Market Size and Forecast, By Type
  - 7.2.7.2. Market Size and Forecast, By Mode of Delivery
  - 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Clinical Pathway Information System Market
  - 7.2.8.1. Market Size and Forecast, By Type
  - 7.2.8.2. Market Size and Forecast, By Mode of Delivery
  - 7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Type
- 7.3.3. Market Size and Forecast, By Mode of Delivery
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France Clinical Pathway Information System Market
  - 7.3.6.1. Market Size and Forecast, By Type
  - 7.3.6.2. Market Size and Forecast, By Mode of Delivery
  - 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. Germany Clinical Pathway Information System Market
  - 7.3.7.1. Market Size and Forecast, By Type
  - 7.3.7.2. Market Size and Forecast, By Mode of Delivery
  - 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Italy Clinical Pathway Information System Market
  - 7.3.8.1. Market Size and Forecast, By Type
  - 7.3.8.2. Market Size and Forecast, By Mode of Delivery
  - 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Spain Clinical Pathway Information System Market
  - 7.3.9.1. Market Size and Forecast, By Type
  - 7.3.9.2. Market Size and Forecast, By Mode of Delivery
  - 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. UK Clinical Pathway Information System Market
  - 7.3.10.1. Market Size and Forecast, By Type
  - 7.3.10.2. Market Size and Forecast, By Mode of Delivery
  - 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest of Europe Clinical Pathway Information System Market
  - 7.3.11.1. Market Size and Forecast, By Type
  - 7.3.11.2. Market Size and Forecast, By Mode of Delivery
  - 7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Type
- 7.4.3. Market Size and Forecast, By Mode of Delivery
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China Clinical Pathway Information System Market
  - 7.4.6.1. Market Size and Forecast, By Type
  - 7.4.6.2. Market Size and Forecast, By Mode of Delivery
  - 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. Japan Clinical Pathway Information System Market
  - 7.4.7.1. Market Size and Forecast, By Type
  - 7.4.7.2. Market Size and Forecast, By Mode of Delivery
  - 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Clinical Pathway Information System Market
  - 7.4.8.1. Market Size and Forecast, By Type
  - 7.4.8.2. Market Size and Forecast, By Mode of Delivery
  - 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. South Korea Clinical Pathway Information System Market
  - 7.4.9.1. Market Size and Forecast, By Type
  - 7.4.9.2. Market Size and Forecast, By Mode of Delivery
  - 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. Australia Clinical Pathway Information System Market
  - 7.4.10.1. Market Size and Forecast, By Type
  - 7.4.10.2. Market Size and Forecast, By Mode of Delivery
  - 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Clinical Pathway Information System Market
  - 7.4.11.1. Market Size and Forecast, By Type
  - 7.4.11.2. Market Size and Forecast, By Mode of Delivery
  - 7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Type
- 7.5.3. Market Size and Forecast, By Mode of Delivery
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Clinical Pathway Information System Market
  - 7.5.6.1. Market Size and Forecast, By Type
  - 7.5.6.2. Market Size and Forecast, By Mode of Delivery
  - 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa Clinical Pathway Information System Market
  - 7.5.7.1. Market Size and Forecast, By Type
  - 7.5.7.2. Market Size and Forecast, By Mode of Delivery
  - 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia Clinical Pathway Information System Market
  - 7.5.8.1. Market Size and Forecast, By Type
  - 7.5.8.2. Market Size and Forecast, By Mode of Delivery
  - 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Clinical Pathway Information System Market
  - 7.5.9.1. Market Size and Forecast, By Type
  - 7.5.9.2. Market Size and Forecast, By Mode of Delivery
  - 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

9.1. McKesson Corporation
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
9.2. Civica
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
9.3. GE Healthcare
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
9.4. Koninklijke Philips N.V.
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
9.5. EPIC Systems Corporation
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
9.6. Optum, Inc.
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
9.7. PointClickCare
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
9.8. Cerner Corporation
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
9.9. Philips Healthcare
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
9.10. Athenahealth
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments